支原体药敏实验结果对治疗泌尿生殖道感染的用药指导

Medication guidance to urogentia tract infection treatment by mycoplosma susceptibility test results

目的了解泌尿生殖道支原体感染及其对抗生素的敏感情况，为临床合理用药提供参考依据。方法对315里泌尿生殖道感染患者进行支原体培养、鉴定、计数及9种抗生素药敏试验检测。结果315例疑似非淋菌性尿道炎患者中支原体阳性率125例，感染率为39．67％；其中解脲脲原体（Uu）感染为101例，占32．06％；人型支原体（Mh）感染为10例，占3．17％：解脲脲原体合并人型支原体（Uu＋Mh）混合感染为14例，占4．44％。支原体药物敏感结果显示：强力霉素、原始霉素交沙霉素、四环素对支原体的药物敏感率分别为99．20％，97．60％，96．80％，94．40％。结论泌尿生殖道支原体培养及其药敏检测，对于指导临床用药治疗具有重要意义，目前强力霉素、原始霉素、交沙霉素、四环素可作为临床支原体感染首选药物。

Objective of mycoplasma infection and its sensitivity to antibiotics in an effort to provide a reference basis for the clinical rational use of drugs. Methods 315 years in patients with urogenital tract infection Mycoplasma culture, identification, counting, and nine kinds of antibiotics susceptibility test for detection. Results of 315 cases of suspected non - gonococcal urethritis patients with positive rate of 125 cases of mycoplasma infection rate of 39.67 % ; of these Ureaplasma urealytieum （Uu） infection in 101 cases, accounting for 32.06 percent; Mycoplasma hominis （Mh） infection in 10 cases, accounting for 3.17 %; Ureaplasma urealyticum and Mycoplasma hominis merger （Uu ＋ Mh） mixed infections was 14 cases, accounting for 4.44%. Mycoplasma drug sensitivity results showed that： doxycycline, pristinamycin, j osarnycin, tetracycline, the drug sensitivity, of Mycoplasma rates were 99.20 %, 97.60%, 96.80 %, 94.40 %. Conclusion mycoplasma culture and drug susceptibility testing to guide clinical use of drugs for the treatment of great significance, the current doxycycline, pristinamycin, josamycin, tetracycline can be used as drug of first choice of cLinical mycoplasma infection.